Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis

References

• Wainwright BJ, Scambler PJ, Schmidtke J et al. Localization of cystic fibrosis locus to human chromosome 7cen-q22. Nature318(6044), 384–385 (1985).
   PubMed Web of Science ®Google Scholar
• Rommens JM, Iannuzzi MC, Kerem B et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science245(4922), 1059–1065 (1989).
   PubMed Web of Science ®Google Scholar
• Riordan JR, Rommens JM, Kerem B et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science245(4922), 1066–1073 (1989).
   PubMed Web of Science ®Google Scholar
• Kerem B, Rommens JM, Buchanan JA et al. Identification of the cystic fibrosis gene: genetic analysis. Science245(4922), 1073–1080 (1989).
   PubMed Web of Science ®Google Scholar
• Maselli JH, Sontag MK, Norris JM, MacKenzie T, Wagener JS, Accurso FJ. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening. Pediatr. Pulmonol.35(4), 257–262 (2003).
   PubMed Web of Science ®Google Scholar
• Littlewood JM, Miller MG, Ghoneim AT, Ramsden CH. Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis. Lancet1(8433), 865 (1985).
   PubMed Web of Science ®Google Scholar
• Valerius NH, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet338(8769), 725–726 (1991).
   PubMed Web of Science ®Google Scholar
• Wiesemann HG, Steinkamp G, Ratjen F et al. Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Pediatr. Pulmonol.25(2), 88–92 (1998).
   PubMed Web of Science ®Google Scholar
• Gibson RL, Emerson J, McNamara S et al. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am. J. Respir. Crit. Care Med.167(6), 841–849 (2003).
   PubMed Web of Science ®Google Scholar
• Johansen HK, Hoiby N. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax47(2), 109–111 (1992).
   PubMed Web of Science ®Google Scholar
• Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev.15(2), 194–222 (2002).
   PubMed Web of Science ®Google Scholar
• Nixon GM, Armstrong DS, Carzino R et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J. Pediatr.138(5), 699–704 (2001).
   PubMed Web of Science ®Google Scholar
• Hudson VL, Wielinski CL, Regelmann WE. Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years. J. Pediatr.122(6), 854–860 (1993).
   PubMed Web of Science ®Google Scholar
• Henry RL, Mellis CM, Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr. Pulmonol.12(3), 158–161 (1992).
   PubMed Web of Science ®Google Scholar
• Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970–1989. Am. J. Epidemiol.143(10), 1007–1017 (1996).
   PubMed Web of Science ®Google Scholar
• Kosorok MR, Zeng L, West SE et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr. Pulmonol.32(4), 277–287 (2001).
   PubMed Web of Science ®Google Scholar
• Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr. Pulmonol.23(5), 330–335 (1997).
   PubMed Web of Science ®Google Scholar
• Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J. Pediatr.116(5), 714–719 (1990).
   PubMed Web of Science ®Google Scholar
• Pamukcu A, Bush A, Buchdahl R. Effects of Pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr. Pulmonol.19(1), 10–15 (1995).
   PubMed Web of Science ®Google Scholar
• Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J. Cyst. Fibros.2(1), 29–34 (2003).
   PubMedGoogle Scholar
• Proesmans M, Balinska-Miskiewicz W, Dupont L et al. Evaluating the “Leeds criteria” for Pseudomonas aeruginosa infection in a cystic fibrosis centre. Eur. Respir. J.27(5), 937–943 (2006).
   PubMed Web of Science ®Google Scholar
• Farrell PM, Govan JR. Pseudomonas serology: confusion, controversy, and challenges. Thorax61(8), 645–647 (2006).
   PubMedGoogle Scholar
• Hayes D Jr, Farrell PM, Li Z, West SE. Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening. Pediatr. Pulmonol.45(1), 55–61 (2010).
   PubMedGoogle Scholar
• Kelly NM, Fitzgerald MX, Tempany E, O’Boyle C, Falkiner FR, Keane CT. Does pseudomonas cross-infection occur between cystic-fibrosis patients. Lancet2(8300), 688–690 (1982).
   PubMedGoogle Scholar
• Speert DP, Lawton D, Damm S. Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp. J. Pediatr.101(2), 227–228 (1982).
   PubMedGoogle Scholar
• Orsi GB, Mansi A, Tomao P, Chiarini F, Visca P. Lack of association between clinical and environmental isolates of Pseudomonas aeruginosa in hospital wards. J. Hosp. Infect.27(1), 49–60 (1994).
   PubMedGoogle Scholar
• Hoiby N, Rosendal K. Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre. Acta Pathol. Microbiol. Scand.88(3), 125–131 (1980).
   Google Scholar
• Pedersen SS, Koch C, Hoiby N, Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J. Antimicrob. Chemother.17(4), 505–516 (1986).
   PubMed Web of Science ®Google Scholar
• Hoiby N, Pedersen SS. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr. Scand.78(3), 395–404 (1989).
   PubMed Web of Science ®Google Scholar
• Jelsbak L, Johansen HK, Frost AL et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in cystic fibrosis lungs. Infect. Immun.75(5), 2214–2224 (2007).
   PubMed Web of Science ®Google Scholar
• Cheng K, Smyth RL, Govan JR et al. Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet348(9028), 639–642 (1996).
   PubMed Web of Science ®Google Scholar
• Edenborough FP, Stone HR, Kelly SJ, Zadik P, Doherty CJ, Govan JR. Genotyping of Pseudomonas aeruginosa in cystic fibrosis suggests need for segregation. J. Cyst. Fibros.3(1), 37–44 (2004).
   PubMedGoogle Scholar
• Chambers D, Scott F, Bangur R et al. Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis. Eur. Respir. J.26(4), 651–656 (2005).
   PubMed Web of Science ®Google Scholar
• Al-Aloul M, Crawley J, Winstanley C, Hart CA, Ledson MJ, Walshaw MJ. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax59(4), 334–336 (2004).
   PubMed Web of Science ®Google Scholar
• McCallum SJ, Corkill JE, Gallagher MJ, Ledson MJ, Hart CA, Walshaw MJ. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa. Lancet358(9281), 558–560 (2001).
   PubMed Web of Science ®Google Scholar
• McCallum SJ, Gallagher MJ, Corkill JE, Hart CA, Ledson MJ, Walshaw MJ. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives. Thorax57(6), 559–560 (2002).
   PubMed Web of Science ®Google Scholar
• Mohan K, Fothergill JL, Storrar J, Ledson MJ, Winstanley C, Walshaw MJ. Transmission of Pseudomonas aeruginosa epidemic strain from a patient with cystic fibrosis to a pet cat. Thorax63(9), 839–840 (2008).
   PubMedGoogle Scholar
• Salunkhe P, Smart CH, Morgan JA et al. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J. Bacteriol.187(14), 4908–4920 (2005).
   PubMedGoogle Scholar
• Fothergill JL, Panagea S, Hart CA, Walshaw MJ, Pitt TL, Winstanley C. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. BMC Microbiol.7, 45 (2007).
   PubMedGoogle Scholar
• Jones AM, Govan JR, Doherty CJ et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet358(9281), 557–558 (2001).
   PubMed Web of Science ®Google Scholar
• Jones AM, Dodd ME, Govan JR et al. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center. Am. J. Respir. Crit. Care Med.171(3), 257–260 (2005).
   PubMed Web of Science ®Google Scholar
• Jones AM, Martin L, Bright-Thomas RJ et al. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa. Eur. Respir. J.22(3), 503–506 (2003).
   PubMed Web of Science ®Google Scholar
• Jones AM, Dodd ME, Doherty CJ, Govan JR, Webb AK. Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa. Thorax57(11), 924–925 (2002).
   PubMed Web of Science ®Google Scholar
• France M, Dodd ME, Govan JR, Doherty CJ, Webb AK, Jones AM. First isolation of Pseudomonas aeruginosa: failure of eradication treatment associated with a clonal strain. Thorax61(Suppl. II), ii34–ii34 (2006).
   Google Scholar
• Denton M, Kerr KG, Mooney L et al. Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center. Pediatr. Pulmonol.34(4), 257–261 (2002).
   PubMed Web of Science ®Google Scholar
• Scott FW, Pitt TL. Identification and characterization of transmissible Pseudomonas aeruginosastrains in cystic fibrosis patients in England and Wales. J. Med. Microbiol.53, 609–615 (2004).
   PubMed Web of Science ®Google Scholar
• Armstrong DS, Nixon GM, Carzino R et al. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am. J. Respir. Crit. Care Med.166(7), 983–987 (2002).
   PubMed Web of Science ®Google Scholar
• Armstrong DS, Bell SC, Robinson M et al. Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. J. Clin. Microbiol.41(5), 2266–2267 (2003).
   PubMed Web of Science ®Google Scholar
• Robinson P, Carzino R, Armstrong DS, Olinsky A. Pseudomonas cross-infection from cystic fibrosis patients to non-cystic fibrosis patients: implications for inpatient care of respiratory patients. J. Clin. Microbiol.41(12), 5741 (2003).
   PubMedGoogle Scholar
• O’Carroll MR, Syrmis MW, Wainwright CE et al. Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. Eur. Respir. J.24(1), 101–106 (2004).
   PubMed Web of Science ®Google Scholar
• Griffiths AL, Jamsen K, Carlin JB et al. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am. J. Respir. Crit. Care Med.171(9), 1020–1025 (2005).
   PubMed Web of Science ®Google Scholar
• Anthony M, Rose B, Pegler MB et al. Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J. Clin. Microbiol.40(8), 2772–2778 (2002).
   PubMed Web of Science ®Google Scholar
• Van Daele SG, Franckx H, Verhelst R et al. Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre. Eur. Respir. J.25(3), 474–481 (2005).
   PubMedGoogle Scholar
• Van Daele SG, Vaneechoutte M, de Boeck K et al. Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients. Eur. Respir. J.28(4), 740–747 (2006).
   PubMedGoogle Scholar
• Fluge G, Ojeniyi B, Hoiby N et al. Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients. Clin. Microbiol. Infect.7(5), 238–243 (2001).
   PubMed Web of Science ®Google Scholar
• Adams C, Morris-Quinn M, McConnell F et al. Epidemiology and clinical impact of Pseudomonas aeruginosa infection in cystic fibrosis using AP-PCR fingerprinting. J. Infect.37(2), 151–158 (1998).
   PubMedGoogle Scholar
• Wolz C, Kiosz G, Ogle JW et al.Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe. Epidemiol. Infect.102(2), 205–214 (1989).
   PubMed Web of Science ®Google Scholar
• Silbert S, Barth AL, Sader HS. Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients. J. Clin.Microbiol.39(11), 3976–3981 (2001).
   PubMedGoogle Scholar
• Speert DP, Campbell ME, Henry DA et al. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am. J. Respir. Crit. Care Med.166(7), 988–993 (2002).
   PubMed Web of Science ®Google Scholar
• Greenberg D, Yagupsky P, Peled N, Goldbart A, Porat N, Tal A. Lack of evidence of transmission of Pseudomonas aeruginosa among cystic fibrosis patients attending health camps at the Dead Sea, Israel. Isr. Med. Assoc. J.6(9), 531–534 (2004).
   PubMed Web of Science ®Google Scholar
• Agarwal G, Kapil A, Kabra SK, Das BK, Dwivedi SN. Characterization of Pseudomonas aeruginosa isolated from chronically infected children with cystic fibrosis in India. BMC. Microbiol.5, 43 (2005).
   PubMed Web of Science ®Google Scholar
• Grothues D, Koopmann U, von der Hardt H, Tummler B. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J. Clin. Microbiol.26(10), 1973–1977 (1988).
   PubMed Web of Science ®Google Scholar
• Schmid J, Ling LJ, Leung JL et al. Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics. Eur. Respir. J.32(6), 1583–1590 (2008).
   PubMedGoogle Scholar
• Doring G, Ulrich M, Muller W et al. Generation of Pseudomonas aeruginosa aerosols during handwashing from contaminated sink drains, transmission to hands of hospital personnel, and its prevention by use of a new heating device. Zentralbl. Hyg. Umweltmed.191(5–6), 494–505 (1991).
   PubMedGoogle Scholar
• Kerr JR, Martin H, Chadwick MV, Edwards A, Hodson ME, Geddes DM. Evidence against transmission of Pseudomonas aeruginosa by hands and stethoscopes in a cystic fibrosis unit. J. Hosp. Infect.50(4), 324–326 (2002).
   PubMedGoogle Scholar
• Panagea S, Winstanley C, Walshaw MJ, Ledson MJ, Hart CA. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. J. Hosp. Infect.59(2), 102–107 (2005).
   PubMed Web of Science ®Google Scholar
• Speert DP, Campbell ME. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis. J. Hosp. Infect.9(1), 11–21 (1987).
   PubMed Web of Science ®Google Scholar
• Zimakoff J, Hoiby N, Rosendal K, Guilbert JP. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic. J. Hosp. Infect.4(1), 31–40 (1983).
   PubMed Web of Science ®Google Scholar
• Humphreys H, Peckham D, Patel P, Knox A. Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis. Thorax49(11), 1157–1159 (1994).
   PubMedGoogle Scholar
• Jones AM, Govan JR, Doherty CJ et al. Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. Thorax58(6), 525–527 (2003).
   PubMed Web of Science ®Google Scholar
• Wainwright CE, France MW, O’Rourke P et al. Cough-generated aerosols of Pseudomonas aeruginosa and other bacteria from cystic fibrosis patients. Thorax64(11), 926–931 (2009).
   PubMed Web of Science ®Google Scholar
• Cox CS. Physical aspects of bioaerosol particles. In: Bioaerosols Handbook. Cox CS, Wathes CS (Eds). Lewis Publishers, FL, USA, 15–25 (1995).
   Google Scholar
• Li Y, Leung G, Tang JW. Role of ventilation in airborne transmission of infectious agents in the built enviroment – a multidisciplinary systematic review. Indoor Air17, 2–18 (2007).
   PubMed Web of Science ®Google Scholar
• Siegel JD, Rhinehart ED, Jackson M, Chiarello L; The Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. CDC, GA, USA (2007).
   Google Scholar
• Tang JW, Li Y, Eames I, Chan PKS, Ridgway GL. Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises. J. Hosp. Infect.64, 100–114 (2006).
   PubMed Web of Science ®Google Scholar
• Duguid JP. The size and duration of air-carriage of respiratory droplets and droplet-nuclei. J. Hygiene44, 471–480 (1946).
   PubMedGoogle Scholar
• Wells WF. On air-borne infection. II. Droplets and droplet nuculei. Am. J. Hygiene20, 611–618 (1934).
   Google Scholar
• Cox CS. Stability of airborne microbes and allergens. In: Bioaerosols Handbook. Cox CS, Wathes CS (Eds). Lewis Publishers, FL, USA, 77–99 (1995).
   Google Scholar
• Hess GE. Effects of oxygen on aerosolized Serratia marcescens. Appl. Microbiol.13(5), 781–787 (1965).
   PubMedGoogle Scholar
• Benbough JE. Death mechanisms in airborne Escherichia coli. J. Gen. Microbiol.47(3), 325–333 (1967).
   PubMedGoogle Scholar
• Heidelberg JF, Shahamat M, Levin M et al. Effect of aerosolization on culturability and viability of Gram-negative bacteria. Appl. Environ. Microbiol.63(9), 3585–3588 (1997).
   PubMed Web of Science ®Google Scholar
• Koller W, Rotter M. [Further investigations on the suitability of gelatine filters for the collection of airborne bacteria]. Zentralbl. Bakteriol.159(5–6), 546–559 (1974).
   Google Scholar
• Crook B. Inertial samplers: biological perspectives. In: Bioaerosols Handbook. Cox CS, Wathes CS (Eds). Lewis Publishers, FL, USA, 247–257 (1995).
   Google Scholar
• Macher JM. Positive-hole correction of multiple-jet impactors for collecting viable microorganisms. Am. Ind. Hyg. Assoc. J.50(11), 561–568 (1989).
   PubMed Web of Science ®Google Scholar
• Somerville MC, Rivers JC. An alternative approach for the correction of bioaerosol data collected with multiple jet impactors. Am. Ind. Hyg. Assoc. J.55(2), 127–131 (1994).
   Web of Science ®Google Scholar
• Jensen PA, Todd WF, Davis GN, Scarpino PV. Evaluation of eight bioaerosol samplers challenged with aerosols of free bacteria. Am. Ind. Hyg. Assoc. J.53(10), 660–667 (1992).
   PubMed Web of Science ®Google Scholar
• Ferroni A, Werkhauser-Bertrand A, Le Bourgeois M et al. Bacterial contamination in the environment of hospitalised children with cystic fibrosis. J. Cyst. Fibros.7(6), 477–482 (2008).
   PubMed Web of Science ®Google Scholar
• Schaal KP. Medical and microbiological problems arising from airborne infection in hospitals. J. Hosp. Infect.18(Suppl. A), 451–459 (1991).
   PubMed Web of Science ®Google Scholar
• Clifton IJ, Fletcher LA, Beggs CB, Denton M, Peckham DG. A laminar flow model of aerosol survival of epidemic and non-epidemic strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis. BMC. Microbiol.8, 105 (2008).
   PubMedGoogle Scholar
• Clifton IJ, Fletcher LA, Beggs CB, Denton M, Conway SP, Peckham DG. An aerobiological model of aerosol survival of different strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis. J. Cyst. Fibros.9, 64–68 (2010).
   PubMed Web of Science ®Google Scholar
• Sultan L, Nyka W, Mills C, O’Grady F, Riley RL, Wells WF. Tuberculosis disseminators. A study of the variability of aerial infectivity of tuberculous patients. Am. Rev. Respir. Dis.82, 358–369 (1960).
   PubMedGoogle Scholar
• Li Y, Yu IT, Xu P et al. Predicting super spreading events during the 2003 severe acute respiratory syndrome epidemics in Hong Kong and Singapore. Am. J. Epidemiol.160(8), 719–728 (2004).
   PubMed Web of Science ®Google Scholar
• Edwards DA, Man JC, Brand P et al. Inhaling to mitigate exhaled bioaerosols. Proc. Natl. Acad. Sci.101(50), 17383–17388 (2004).
   PubMed Web of Science ®Google Scholar
• Roberts K, Hathway A, Fletcher LA, Beggs CB, Elliott MW, Sleigh PA. Bioaerosol production on a respiratory ward. Indoor Built Environ.15, 35–40 (2006).
   Web of Science ®Google Scholar
• Department of Health/Estates and Facilities Division. Health Technical Memorandum 03–01: Specialised Ventilation for Healthcare Premises. Part A – Design and Installation. The Stationary Office, London, UK (2007).
   Google Scholar
• Qian H, Li Y, Nielsen PV, Hyldgaard CE, Wong TW, Chwang ATY. Dispersion of exhaled droplet nuclei in a two-bed hospital ward with three different ventilation systems. Indoor Air16, 111–128 (2006).
   PubMed Web of Science ®Google Scholar
• Cairns G, Kerr KG, Beggs CB et al. Susceptibility of Burkholderia cepacia and other pathogens of importance in cystic fibrosis to u.v. light. Lett. Appl. Microbiol.32(3), 135–138 (2001).
   PubMedGoogle Scholar
• UK CF Trust Control of Infection Group. Pseudomonas aeruginosa infection in people with cystic fibrosis. Suggestions for prevention and infection control. Cystic Fibrosis Trust, Kent, UK (2004).
   Google Scholar